Retinal biomarkers in cognitive impairment and dementia: Structural, functional, and molecular insights
Open Access
- 10 September 2025
- journal article
- review article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (9) , e70672
Abstract
Cognitive impairment and dementia, including Alzheimer's disease (AD), pose a global health crisis, necessitating non‐invasive biomarkers for early detection. This review highlights the retina, an accessible extension of the central nervous system (CNS), as a window to cerebral pathology through structural, functional, and molecular alterations. By synthesizing interdisciplinary evidence, we identify retinal biomarkers as promising tools for early diagnosis and risk stratification. Nevertheless, translating biomarkers into clinical practice faces significant translational hurdles, including methodological heterogeneity, confounding variables, lack of standardized protocols, and insufficient longitudinal validation in diverse populations. Overcoming these challenges through rigorous standardization and robust validation studies is essential to establish the clinical utility of retinal biomarkers. Highlights: Stage‐specific diagnostic potential: Retinal biomarkers (e.g., OCT/OCTA changes, eye movements, molecular deposits) show alterations correlating with cognitive impairment stages (preclinical AD to dementia), assisting stage differentiation. Reflecting cerebral pathology: Multimodal retinal alterations (structural, functional, molecular) correlate with key brain pathologies (amyloid/tau burden, atrophy, small vessel disease), indicating shared pathways. Translation gaps and future: Clinical adoption faces barriers (method heterogeneity, confounders, limited validation). Future requires rigorous screening of candidate retinal biomarkers, extensive multicenter validation, and artificial intelligence (AI)‐facilitated clinical translation.Keywords
This publication has 289 references indexed in Scilit:
- Visual Evoked Potentials in Early Alzheimer's Dementia: An Exploratory StudyThe Journal of General Psychology, 1995
- Retinal ganglion cell degeneration in Alzheimer's diseaseBrain Research, 1989
- Abnormal pattern electroretinogram in Alzheimer's disease: Evidence for retinal ganglion cell degeneration?Annals of Neurology, 1989
- Abnormal pattern electroretinograms in patients with senile dementia of the alzheimer typeAnnals of Neurology, 1989
- Visual evoked potentials in dementia: A meta-analysis and empirical study of Alzheimer's disease patientsBiological Psychiatry, 1989
- Assessment of Visual Impairment in Patients With Alzheimer's DiseaseAmerican Journal of Ophthalmology, 1987
- Saccadic eye movement dysfunction in Alzheimer's diseaseAnnals of Neurology, 1986
- Optic-Nerve Degeneration in Alzheimer's DiseaseNew England Journal of Medicine, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- The Global Deterioration Scale for assessment of primary degenerative dementiaAmerican Journal of Psychiatry, 1982